National Health Surveillance Agency of Brazil (Anvisa) to Grant Special Temporary Registration for Oxitec’s GE Mosquito
OX513A Fights Primary Mosquito Vector of Dengue, Zika and Chikungunya Viruses
Oxford, UK, 13 April 2016 – The National Health Surveillance Agency of Brazil (Anvisa) announced yesterday they would grant a special temporary registration (RET, Registro Especial Temporário) to Oxitec to deploy its genetically engineered mosquito, OX513A, known as Friendly Aedes aegypti, throughout the country.
Oxitec’s biological approach to control the spread of the Aedes aegypti mosquito, the primary vector for transmitting dengue, Zika and chikungunya viruses to humans, was approved by National Technical Biosafety Commission (CTNBio) in 2014. However at that time, Anvisa did not yet have legislation in place to regulate this innovative class of vector control technology. With the guidance issued, Anvisa is elaborating new rules to provide Brazil with a regulatory framework that is able to deal with this and any similar products that may be developed.
In the interim Anvisa will grant Oxitec the freedom to use Friendly Aedes aegypti in projects across the country. This should assist the development of the product within Brazil so that it can be used as part of programs designed to fight Aedes aegypti, the dangerous vector of dengue, chikungunya and Zika.